HDT-301

· HDT Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HDT-301, covering 2024-10-23 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein [Phase 1]